JP2023501968A5 - - Google Patents

Info

Publication number
JP2023501968A5
JP2023501968A5 JP2022525745A JP2022525745A JP2023501968A5 JP 2023501968 A5 JP2023501968 A5 JP 2023501968A5 JP 2022525745 A JP2022525745 A JP 2022525745A JP 2022525745 A JP2022525745 A JP 2022525745A JP 2023501968 A5 JP2023501968 A5 JP 2023501968A5
Authority
JP
Japan
Prior art keywords
compound
composition according
group
unconjugated
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022525745A
Other languages
English (en)
Japanese (ja)
Other versions
JP7653429B2 (ja
JP2023501968A (ja
Filing date
Publication date
Priority claimed from US16/667,807 external-priority patent/US11174229B2/en
Application filed filed Critical
Publication of JP2023501968A publication Critical patent/JP2023501968A/ja
Publication of JP2023501968A5 publication Critical patent/JP2023501968A5/ja
Priority to JP2024208343A priority Critical patent/JP2025023120A/ja
Application granted granted Critical
Publication of JP7653429B2 publication Critical patent/JP7653429B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022525745A 2018-10-29 2020-02-21 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス Active JP7653429B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024208343A JP2025023120A (ja) 2018-10-29 2024-11-29 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862752324P 2018-10-29 2018-10-29
US201962800494P 2019-02-02 2019-02-02
US16/667,807 US11174229B2 (en) 2018-10-29 2019-10-29 D-amphetamine compounds, compositions, and processes for making and using the same
US16/667,807 2019-10-29
PCT/US2020/019146 WO2021086427A1 (en) 2018-10-29 2020-02-21 D-amphetamine compounds, compositions, and processes for making and using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024208343A Division JP2025023120A (ja) 2018-10-29 2024-11-29 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス

Publications (3)

Publication Number Publication Date
JP2023501968A JP2023501968A (ja) 2023-01-20
JP2023501968A5 true JP2023501968A5 (https=) 2023-02-06
JP7653429B2 JP7653429B2 (ja) 2025-03-28

Family

ID=70328134

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2022525745A Active JP7653429B2 (ja) 2018-10-29 2020-02-21 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2022525742A Active JP7653428B2 (ja) 2018-10-29 2020-02-21 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2024071955A Active JP7830540B2 (ja) 2018-10-29 2024-04-25 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2024208343A Pending JP2025023120A (ja) 2018-10-29 2024-11-29 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2025131588A Pending JP2025163212A (ja) 2018-10-29 2025-08-06 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2022525742A Active JP7653428B2 (ja) 2018-10-29 2020-02-21 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2024071955A Active JP7830540B2 (ja) 2018-10-29 2024-04-25 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2024208343A Pending JP2025023120A (ja) 2018-10-29 2024-11-29 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス
JP2025131588A Pending JP2025163212A (ja) 2018-10-29 2025-08-06 ｄ－アンフェタミン化合物、組成物、ならびにそれを作製および使用するためのプロセス

Country Status (13)

Country Link
US (4) US11174229B2 (https=)
EP (2) EP4051268A4 (https=)
JP (5) JP7653429B2 (https=)
KR (3) KR20220088727A (https=)
CN (2) CN114746091A (https=)
AU (2) AU2020372736A1 (https=)
BR (2) BR112022008208A2 (https=)
CA (2) CA3158405A1 (https=)
IL (2) IL292496A (https=)
MX (2) MX2022005013A (https=)
PH (2) PH12022551047A1 (https=)
WO (2) WO2021086426A1 (https=)
ZA (2) ZA202204678B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11174229B2 (en) * 2018-10-29 2021-11-16 Kempharm, Inc. D-amphetamine compounds, compositions, and processes for making and using the same
CN120131637A (zh) * 2025-05-08 2025-06-13 中国人民解放军海军军医大学 左乙拉西坦在制备抗疲劳的药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02504509A (ja) * 1987-08-07 1990-12-20 ジ・アップジョン・カンパニー 非ペプチド結合を有するレニン抑制ペプチド
DE4234012A1 (de) * 1992-10-09 1994-04-14 Basf Ag Neue Anilinderivate und diese enthaltende Pflanzenschutzmittel
AU1494702A (en) * 2000-11-21 2002-06-03 Leo Pharma As Cyanoguanidine prodrugs
SI1644019T2 (en) 2003-05-29 2018-04-30 Shire Llc Abuse resistant amphetamine compounds
US8163701B2 (en) 2005-08-19 2012-04-24 Signature Therapeutics, Inc. Prodrugs of active agents
CA2763172A1 (en) 2009-05-26 2010-12-02 David Hackett Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
CA3123900A1 (en) * 2011-07-28 2013-01-31 Kempharm Inc. Methylphenidate-prodrugs, processes of making and using the same
BR102012004888A2 (pt) 2012-03-05 2013-10-22 Phartrials Pesquisas Farmaceuticas Ltda Associação de um derivado de sulfamato monossubstituído do monossacarídeo natural d-frutose (topiramato) com um anti-depressivo da classe das fenilcetonas (bupropiona) para tratamento de obesidade e das síndromes plurimetabólicas
US20140073589A1 (en) * 2012-06-27 2014-03-13 Shire Ag Amphetamine Prodrugs
AU2013326850B2 (en) * 2012-10-04 2017-09-21 Inhibikase Therapeutics, Inc. Novel compounds, their preparation and their uses
JP6621329B2 (ja) * 2012-10-05 2019-12-18 スファエラ ファーマ ピーティーイー リミテッド 新規化合物、それらの合成及びそれらの使用
ITUA20161706A1 (it) * 2016-03-15 2017-09-15 Cyanagen S R L Nuovi coloranti cumarinici e relativi coniugati
HUE067004T2 (hu) * 2016-12-11 2024-10-28 Zevra Therapeutics Inc Metilfenidát prodrogokat tartalmazó készítmények, eljárások azok elõállítására és felhasználására
US20200114014A1 (en) 2017-04-11 2020-04-16 John K. Thottathil Novel Alpha-Hydroxy Carboxylic Acid and Derivatives and Other GRAS-Based Amide and Imide Prodrugs of Amphetamine Compounds and Uses Thereof
US20200109117A1 (en) * 2018-10-02 2020-04-09 ACCESS Association Modified Therapeutic Agent Analogs of Mefenamic Acid
US11174229B2 (en) * 2018-10-29 2021-11-16 Kempharm, Inc. D-amphetamine compounds, compositions, and processes for making and using the same

Similar Documents

Publication Publication Date Title
CN1146421C (zh) 治疗疼痛的组合物以及药物在制备所述组合物中的应用
TWI598098B (zh) 脂質異常症治療劑
JP2025163212A5 (https=)
RU2014107678A (ru) Пролекарства метилфенидата, способы их получения и применения
JP2008521827A5 (https=)
CN110234636B (zh) 包含哌醋甲酯前药的组合物，其制造和使用方法
JP2023501968A5 (https=)
JP2005015434A (ja) 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
JP2023501967A5 (https=)
JP2024507810A5 (https=)
US20190381017A1 (en) Compositions Comprising Serdexmethylphenidate Conjugates And Methods Of Use Thereof
DE02729306T1 (de) Substituierte azolsäurederivate, die sich als mittel gegen diabetes und obesitas eignen, und verfahren
CA2862193C (en) Antituberculosis drug combination comprising oxazole compounds
WO2014008374A2 (en) Combination therapies comprising metformin salts and antihyperglycemia agents or antihyperlipidemia agents
CA2865845C (en) An iloperidone metabolite for use in the treatment of psychiatric disorders
JP2021522246A (ja) 癌治療のための併用
CN115304593A (zh) 苯并异噻唑化合物及其药物组合物和应用
JPWO2019131901A1 (ja) ピリジルアミノ酢酸化合物を含有する医薬製剤
CH679553A5 (https=)
US20020147206A1 (en) Combination treatment of multiple sclerosis (MS), other demyelinating conditions and peripheral neuropathy, especially painful neuropathies and diabetic neuropathy
NZ787387B2 (en) D-amphetamine compounds, compositions, and processes for making and using the same
WO2014008379A2 (en) Diamine and meglumine salt forms of fatty acids
TWI227135B (en) Use of 2-amino-3,4-dihydroquinazolines for the production of a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditions
JP7535797B2 (ja) 化合物バフィデムスタット（ｖａｆｉｄｅｍｓｔａｔ）などｋｄｍ１ａ阻害剤を使用した注意欠陥多動性障害の処置方法
NZ787388A (en) D-amphetamine compounds, compositions, and processes for making and using the same